AlphaCore Capital LLC Purchases Shares of 4,276 The Clorox Company (NYSE:CLX)

AlphaCore Capital LLC bought a new position in The Clorox Company (NYSE:CLX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 4,276 shares of the company's stock, valued at approximately $694,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Redwood Park Advisors LLC acquired a new position in shares of Clorox during the fourth quarter worth approximately $26,000. Millstone Evans Group LLC acquired a new position in shares of Clorox during the fourth quarter worth approximately $31,000. Asset Planning Inc acquired a new position in Clorox during the 4th quarter worth $32,000. GKV Capital Management Co. Inc. acquired a new position in Clorox during the 4th quarter worth $32,000. Finally, Aster Capital Management DIFC Ltd acquired a new position in Clorox during the 4th quarter worth $33,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Pierre R. Breber bought 4,000 shares of the company's stock in a transaction on Wednesday, May 7th. The shares were purchased at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the acquisition, the director now owns 4,000 shares of the company's stock, valued at approximately $546,280. This represents a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.57% of the company's stock.

Clorox Trading Down 0.1%

CLX traded down $0.19 during mid-day trading on Wednesday, hitting $130.17. The stock had a trading volume of 1,548,732 shares, compared to its average volume of 1,338,209. The stock's fifty day simple moving average is $139.05 and its 200-day simple moving average is $151.85. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The firm has a market capitalization of $16.04 billion, a price-to-earnings ratio of 35.57, a price-to-earnings-growth ratio of 2.62 and a beta of 0.60. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.12). The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.74 billion. Clorox had a return on equity of 316.87% and a net margin of 6.38%. The business's quarterly revenue was down 8.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.71 EPS. As a group, research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have issued reports on CLX. Wells Fargo & Company reduced their price objective on Clorox from $145.00 to $142.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Barclays cut their price target on Clorox from $134.00 to $129.00 and set an "underweight" rating on the stock in a research note on Wednesday, May 7th. JPMorgan Chase & Co. cut their price target on Clorox from $151.00 to $144.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 6th. Morgan Stanley cut their target price on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Finally, DA Davidson cut their target price on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 5th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $151.23.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.